Healthcare Sales & Marketing Network News: AdNectin

Searching News Database: AdNectin

HSMN NewsFeed - 25 Feb 2022
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biopharmaceuticals Licensing

HSMN NewsFeed - 15 May 2009
Avila Therapeutics Appoints Katrine S. Bosley as Company's First CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Bristol-Myers Squibb to Acquire Adnexus Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Jul 2007
Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2007
Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Nov 2006
Adnexus Therapeutics Appoints Bruce A. Silver, MD, FACP as Medical Director
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Jun 2006
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
Biopharmaceuticals Oncology

Return to NewsFeed

Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 5 additional stories matching:
AdNectin
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!